Effect of Expectation of Care on Adherence to Antihypertensive Medications Among Hypertensive Blacks: Analysis of the Counseling African Americans to Control Hypertension (CAATCH) Trial

Journal of Clinical Hypertension

Volumn 18, Issue 7, 2016, Pages 690-696

  Grant, Andrea Barnes ^a,b   Seixas, Azizi ^c   Frederickson, Keville ^a,d   Butler, Mark ^c   Tobin, Jonathan N ^e,f,g   Jean Louis, Girardin ^c   Ogedegbe, Gbenga ^c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d PACE UNIVERSITY   (United States)

^e Clinical Directors Network   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BLACK PERSON; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; EMPLOYMENT STATUS; EXPECTATION; FEMALE; HEALTH INSURANCE; HUMAN; HYPERTENSION; INCOME; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL SUPPORT;

EID: 84978863765     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12736     Document Type: Article

References (49)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;128:1–268.
2. Wong MD, Shapiro MF, Boscardin WJ, et al. Contribution of major disease to disparities in mortality. N Engl J Med. 2002;347:1585–1592.
3. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146.
4. Bosworth HB, Powers B, Grubber JM, et al. Racial differences in blood pressure control: potential explanatory factors. J Gen Intern Med. 2008;23:692–698.
5. Fiscella K, Holt K. Racial disparity in hypertension control: tallying the death toll. Ann Fam Med. 2008;6:497–502.
6. Chobanian AV, Bakris G, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–1252.
7. Batson B, Belletti D, Wogenthan J. Effect of African American Race on hypertension management: a real world observational study among 28 US physician practices. Ethn Dis. 2010;10:409–415.
8. Charles H, Good C, Hanusa B, et al. Racial differences in adherence to cardiac medications. J Natl Med Assoc. 2003;95:17–27.
9. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the department of veterans affairs. Am J Med. 2007;120:26–32.
10. Poon I, Lal LS, Ford ME, et al. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study. Ann Pharmacother. 2009;43:199–206.
11. Knight EL, Bohn RL, Wang PS, et al. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001;38:809–814.
12. Hyre AD, Krousel-Wood MA, Muntner P, et al. Prevalence and predictors of poor antihypertensive medication adherence in urban health clinic setting. J Clin Hypertens (Greenwich). 2007;9:179–186.
13. Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older Americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003;163:6681–6687.
14. Douglas JG, Ferdinand KC, Bakis GL, et al. Barriers to blood pressure control in African Americans. Overcoming obstacles is challenging, but target goals can be attained. Postgrad Med. 2002;112:51–52 59–62.
15. Bell RA, Kravitz RL, Thom D, et al. Unmet expectations for care and the patient-physician relationship. J Gen Intern Med. 2002;17:817–824.
16. Miller RH, Williams PC, Napolitana G, et al. Malpractice: a case control study of claimants. J Gen Intern Med. 1990;5:244–248.
17. Uhlmann RF, Inui TS, Carter WB. Patient requests and expectations. Definitions and clinical applications. Med Care. 1984;22:681–685.
18. Kim EY, Han HR, Jeong S, et al. Does knowledge matter? Intentional medication non-adherence among middle-aged Korean Americans with high blood pressure. J Cardiovasc Nurs. 2007;22:397–404.
19. Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–354.
20. Ogedegbe G, Harrison M, Robbins L, et al. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn Dis. 2004;14:3–13.
21. Fongwa MN, Evangelista LS, Hays RD, et al. Adherence treatment factors in hypertensive African American women. Vasc Health Risk Manag. 2008;4:157–166.
22. Lewis LM, Askie P, Randleman S, et al. Medication adherence beliefs of community-dwelling hypertensive African Americans. J Cardiovasc Nurs. 2010;25:199–206.
23. Flynn SJ, Ameling JM, Hill-Briggs F, et al. Facilitators and barriers to hypertension self-management in urban African Americans: perspectives of patients and family members. Patient Prefer Adherence. 2013;7:741–749.
24. Ogedegbe G, Tobin JN, Fernandez S, et al. Counseling African Americans to Control Hypertension (CAATCH) trial: a multi-level intervention to improve blood pressure control in hypertensive blacks. Circ Cardiovasc Qual Outcomes. 2009;2:249–256.
25. Allison C. BpTRU(tm) blood pressure monitor for use in a physician's office. Issues Emerg Health Technol. 2006;86:1–4.
26. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens. 2009;27:280–286.
27. Crum RM, Anthony JC, Bassett SS. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386–2391.
28. Shea S, Misra D, Ehrlich MH, et al. Correlates of non-adherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82:1607–1612.
29. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.
30. Carter-Edwards L, Jackson SA, Runaldue MJ, et al. Diet- and blood pressure-related knowledge, attitudes, and hypertension prevalence among African Americans: KDBP study. Knowledge of diet and blood pressure. Ethn Dis 2002;12:S1-72–82.
31. Ford ES, Jones DH. Cardiovascular health knowledge in the United States: findings from the National Health Interview Survey, 1985. Prev Med. 1991;20:725–736.
32. National High Blood Pressure Education Program (NHBPEP). Check Your High Blood Pressure Prevention IQ (Questionnaire). Bethesda, MD: US-DHHS; 1994, NIH Publi. No. 94-3471.
33. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705–714.
34. Rotter JB. Social Learning and Clinical Psychology. New York: Prentice-Hall; 1954.
35. Lazare A, Eisenthal S, Frank A. Clinician/patient relations II: conflict and negotiation. In: Lazare A, ed. Outpatient Psychiatry: Diagnosis and Treatment. Baltimore, MD: Williams and Wilkins; 1989:137–152.
36. Ogedegbe G, Mancuso CA, Allegrante JP. Expectations of blood pressure management in hypertensive African-American patients: a qualitative study. J Natl Med Assoc. 2004;96:442–449.
37. Okwuonu CG, Ojimadu NE, Okaka EI, et al. Patient-related barriers to hypertension control in a Nigerian population. Int J Gen Med. 2014;7:345–353.
38. Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. New York: Guildford Press; 2014.
39. Preacher KJ, Hayes AF. SPSS and SAS Procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36:717–731.
40. Gascón JJ, Sánchez-Ortuño M, Llor B, et al. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract. 2004;21:125–130.
41. Kressin NR, Wang F, Long J, et al. Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med. 2007;22:768–774.
42. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84:191–215.
43. Lewis LM, Schoenthaler AM, Ogedegbe G. Patient factors, but not provider and health care system factors, predict medication adherence in hypertensive black men. J Clin Hypertens (Greenwich). 2012;14:250–255.
44. Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav 2009;36:127–137.
45. Heurtin-Roberts S, Reisin E. The relation of culturally influenced lay models of hypertension to compliance with treatment. Am J Hypertens. 1992;5:787–792.
46. Wal P, Wal A, Bhandari A, et al. Pharmacist involvement in the patient care improves outcome in hypertension patients. J Res Pharm Pract. 2013;2:123–129. doi:10.4103/2279-042X.122386.
47. Rashid A, Rahman A, Wang J, et al. Perception of hypertension management by patients and doctors in Asia: potential to improve blood pressure control. Asia Pac Fam Med. 2015;14:2–11. doi:10.1186/s12930-015-0018-3.
48. Jaffe MG, Lee GA, Young JD, et al. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310:699–705.
49. Bangalore S, Ogedegbe G, Gyamfi J, et al. Outcomes with angiotensin-converting enzyme inhibitors vs other antihypertensive agents in hypertensive blacks. Am J Med. 2015; 9343; 00445–3.